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The postnatal development of the mouse is characterized by a stress hypo-responsive period 
(SHRP), where basal corticosterone levels are low and responsiveness to mild stressors is 
reduced. Maternal separation is able to disrupt the SHRP and is widely used to model early 
trauma. In this study we aimed at identifying of brain systems involved in acute and possible 
long-term effects of maternal separation. We conducted a microarray-based gene expression 
analysis in the hypothalamic paraventricular nucleus after maternal separation, which revealed 52 
differentially regulated genes compared to undisturbed controls, among them are 37 up-regulated 
and 15 down-regulated genes. One of the prominently up-regulated genes, angiotensinogen, 
was validated using in-situ hybridization. Angiotensinogen is the precursor of angiotensin II, 
the main effector of the brain renin-angiotensin system (RAS), which is known to be involved in 
stress system modulation in adult animals. Using the selective angiotensin type I receptor [AT(1)] 
antagonist candesartan we found strong effects on CRH and GR mRNA expression in the brain and 
ACTH release following maternal separation. AT(1) receptor blockade appears to enhance central 
effects of maternal separation in the neonate, suggesting a suppressing function of brain RAS 
during the SHRP . Taken together, our results illustrate the molecular adaptations that occur in 
the paraventricular nucleus following maternal separation and contribute to identifying signaling 
cascades that control stress system activity in the neonate.
Keywords: postnatal, stress hypo-responsive period, mouse, maternal separation, paraventricular nucleus, microarray, 
renin-angiotensin system, candesartan
However, due to the wide variability of postnatal manipulations, 
species and strain differences, the data on the long-term effects of 
early life stress are often inconsistent. For instance, while many 
authors have shown an increased anxiety after postnatal stress 
(Veenema et al., 2008), other reports show no clear phenotype 
(Millstein and Holmes, 2007) or even a decreased anxiety (Fabricius 
et al., 2008). One of the main problems in understanding these dif-
ferent outcomes is the lack of knowledge about the acute effects of 
the different postnatal stress paradigms.
The mechanism of HPA axis regulation during the SHRP is 
intriguing, as it may explain possible regulatory pathways in the 
adult animals. We could recently show that an apparently enhanced 
glucocorticoid receptor-mediated feedback plays an essential role 
in maintaining low stress responsiveness in the neonate (Schmidt 
et al., 2005, 2009). Metabolic signals, which are altered due to mater-
nal separation, activate the arcuate nucleus and seem to overcome 
this GR blockade via an CRH-mediated central pathway (Schmidt 
et al., 2006a,b). In addition, maternal signals as licking and groom-
ing have been identiﬁ  ed as essential parameters to ensure low HPA-
system activity (Suchecki et al., 1993; van Oers et al., 1998).
Most of the current knowledge about the HPA axis regulation 
in the neonate is thus based on hypothesis-driven approaches. 
However, additional, so far uninvestigated brain systems are likely to 
contribute to the acute and long-term effects of maternal  separation 
and early trauma. In the current study we therefore addressed 
INTRODUCTION
During ontogeny the hypothalamic-pituitary-adrenal (HPA) axis 
undergoes a period of quiescence (Levine et al., 1967; Schapiro 
et al., 1962). This so-called stress hypo-responsive period (SHRP), 
which in the mouse lasts from about postnatal day 1 to postnatal day 
12 (Schmidt et al., 2003a), is characterized by low basal corticoster-
one levels and a decreased responsiveness to a variety of stressors 
(Cirulli et al., 1992; Rosenfeld et al., 1992; Schmidt et al., 2002b).
Although suppressed in response, the stress system of the neonate 
is still capable to respond to more severe and possibly life threatening 
challenges, as e.g. exposure to cold or ether fumes (Schoenfeld et al., 
1980; Walker and Dallman, 1993; Walker et al., 1991). A profound 
activation of the HPA axis occurs following prolonged separation 
of maternal signals, which not only increases basal corticosterone 
levels, but also enhances the responsiveness of the stress system to 
mild challenges (Levine, 2001; Schmidt et al., 2004).
Disruption of the SHRP, which has also been postulated to exist 
to some extent in humans (Gunnar, 1998; Gunnar and Donzella, 
2002), has been shown to result in numerous long-lasting behavio-
ral and neuroendocrine consequences in both humans and animals 
(Bernet and Stein, 1999; Heim et al., 2000, 2002; Plotsky et al., 2005; 
Weaver et al., 2004). While most of the earlier work was performed 
in rats, many recent studies studied early life stress paradigms using 
mice (Cruz et al., 2008; Kawakami et al., 2007; Macri and Laviola, 
2004; Marco et al., 2009; Ognibene et al., 2008; Rice et al., 2008). 
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this question by performing a microarray-based gene expression 
  analysis of maternally separated and non-separated mouse pups. 
We selected the paraventricular nucleus (PVN) as a main region of 
interest, as most of the acute gene expression changes due to mater-
nal separation have so far been reported for this brain structure. 
Based on a gene expression proﬁ  ling approach we are able to iden-
tify and functionally validate the brain renin-angiotensin system as 
a modulator of stress system function during the SHRP.
MATERIALS AND METHODS
ANIMALS
The offspring of 3-month-old C57Bl6/N mice (obtained from Charles 
River) was used in this study. After a habituation period of 1 week, 
two females were mated with one male in standard mouse polycar-
bonate cages (45 × 25 × 20 cm) containing sawdust bedding. Pregnant 
females were single housed and transferred to clean polycarbonate 
cages containing sawdust and two sheets of paper towels for nest mate-
rial during the last week of gestation. Pregnant females were checked 
for litters daily between 9 and 10 a.m. If litters were found, the day of 
birth was deﬁ  ned as day 0 for that litter. On the day after parturition, 
day 1, each litter was culled to eight healthy pups (four males and four 
females) and remained undisturbed until used in the experiment. All 
animals were housed under a 12L:12D cycle (lights on at 6 a.m.) and 
constant temperature (23 ± 2°C) and humidity (55 ± 5%) conditions. 
Food and water was provided ad libitum.
The experiments were carried out in accordance with European 
Communities Council Directive 86/609/EEC. All efforts were made 
to minimize animal suffering during the experiments. The protocols 
were approved by the committee for the Care and Use of Laboratory 
Animals of the Government of Upper Bavaria, Germany.
EXPERIMENTAL DESIGN
Experiment 1: gene expression proﬁ  le
A total of 6 litters were used in the study. Litters were randomly 
assigned  to  either a maternally non-separated or 24-h mater-
nally   separated condition. All pups from a litter were sacriﬁ  ced 
by   decapitation and trunk blood was collected immediately after 
the 24-h   deprivation period or – in the case of the control litters – 
  immediately after separation from the mother on postnatal day 9.
Experiment 2: functional validation
A total of 8 litters were used in the study. Each nest was assigned 
randomly to one of the two conditions, 8-h maternal separation or 
non- separated control. Pups in each litter were either treated subcu-
taneously with vehicle (saline) or 1 mg/kg of the angiotensin type I 
receptor AT(1) antagonist candesartan (provided by AstraZeneca, 
Wedel, Germany) 2 h after the onset of separation (6 h before 
testing). The dosage of the drug was based on literature reports 
(Armando et al., 2007; Fan et al., 2004) and it has been demon-
strated that candesartan crosses the blood-brain barrier (Pavel et al., 
2008). The injection volume was 30 µl. At the time of testing, all 
pups from a litter were sacriﬁ  ced by decapitation.
MATERNAL SEPARATION
Maternal separation took place in a separate room in the animal 
facility under similar light and temperature conditions as men-
tioned previously. The initiation day of maternal separation for all 
experiments was postnatal day 8. If a nest was assigned to maternal 
separation, mothers were removed from their home cages between 
8 and 10 a.m. The home cage, containing the litter, was then placed 
on a heating pad maintained at 30–33°C. Neither food nor water 
was available during the separation period. In experiment 1, separa-
tion lasted for 24 h. In experiment 2, pups were only separated for 
8 h, in order to assess the role of the brain renin-angiotensin system 
in activating the HPA axis. The 8-h time-point was chosen based 
on earlier studies, which indicated a full activation of the HPA axis 
during the ﬁ  rst 8 h of separation (Schmidt et al., 2004).
SAMPLING PROCEDURE
Trunk blood from all pups was collected individually in labeled 1.5 ml 
EDTA-coated microcentrifuge tubes. All blood samples were kept 
on ice and later centrifuged for 15 min at 6000 rpm at 4°C. Plasma 
was transferred to clean, labeled 1.5 ml microcentrifuge tubes. All 
plasma samples were stored frozen at −20°C until the determination 
of corticosterone (experiments 1 and 2) and ACTH (experiment 2). 
ACTH and corticosterone were measured by RIA (MP Biomedicals 
Inc.; sensitivity 10 pg/ml and 6.25 ng/ml, respectively). Whole heads 
(without skin and jaw) were removed, frozen in isopropane and 
stored at −80°C for microarray analysis or in-situ hybridization.
MICROARRAY PROCEDURE
The brains of six animals per group were used. Frozen brains were 
sectioned at −20°C in a cryostat microtome at 100 µm in the coronal 
plane through the level of the hypothalamic PVN. The sections 
were mounted on superfrost plus slides (Menzel, Braunschweig, 
Germany) and tissue micropunches were taken using a sample corer 
of 1 mm diameter (Fine Science Tools, Heidelberg, Germany). The 
PVNs of two animals from the same group were pooled into one 
sample, giving a total of three samples for each treatment. Punches 
were immediately transferred to frozen 1.5 ml plastic tubes and 
stored ad −80°C until RNA isolation. The accuracy of the punch was 
controlled by cresyl violet counterstaining of the punched sections 
and conﬁ  rming the punch location under a light microscope.
Total RNA of the punched tissue was isolated with the Trizol 
(Invitrogen GmbH, Karlsruhe, Germany) method following the 
manufacturers’ protocol. Isolated RNA was then ampliﬁ  ed  in 
one round using the Ambion Amino Allyl MessageAmp aRNA 
kit (Ambion, Huntingdon, UK). RNA samples were quantiﬁ  ed 
by spectrophotometry and RNA integrity checked on 1% agar-
ose gels using a deionized formamide-based loading buffer. Equal 
amounts of total aRNA were pooled to one “non-separated” and 
one “separated” sample containing 40 µg of aRNA each and dye 
coupled using indirect labeling. To exclude dye bias, one-half of 
each sample was coupled to cyanine 3 (Cy3) and the other one-
half to cyanine 5 (Cy5). The pooled samples were hybridized on 
ﬁ  ve Max-Planck Institute 24 k mouse cDNA arrays (Max-Planck 
Institute of Psychiatry, Munich, Germany) for each dye coupling 
combination (10 arrays total) and scanned on a PerkinElmer Life 
Sciences (Rodgau-Jügesheim, Germany) ScanArray 4000 laser scan-
ner as described previously (Deussing et al., 2007).
IN-SITU HYBRIDIZATION
The brains of eight animals per group were used for in-situ hybridi-
zation (different animals than used for microarray analysis). Frozen Frontiers in Molecular Neuroscience  www.frontiersin.org  May  2009 | Volume  2 | Article  1 | 3
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genes. Of these genes, 37 were up-regulated in the maternally 
 separated group (see Table 1), while 15 genes were down- regulated 
(see Table 2). Maternal separation affected the expression of genes 
involved in various different functions, including apoptosis, met-
abolic processes, signal transduction, cell-cell interaction, gene 
expression, development, cellular transport or proliferation. For 
the current study, we chose to focus on the involvement of the angi-
otensinogen gene (AGT) in maternal separation for further valida-
tion and follow-up studies. The up- regulation of AGT in separated 
animals suggested a functional role of the brain renin-angiotensin 
system (RAS) in regulating the response to maternal separation. 
This system has previously been indicated to be involved in stress 
system regulation and dysregulation in adulthood (Armando et al., 
2001, 2007; Plotsky et al., 1988; Raasch et al., 2006). In addition, 
genetic variation in genes involved in the brain RAS have been 
linked to disorders as unipolar depression or panic disorder (Baghai 
et al., 2006; Olsson et al., 2004). However, few data on the involve-
ment of the brain RAS in regulating the HPA axis during ontogeny 
are available.
Validation by in-situ hybridization
In-situ hybridization was used to independently verify the results 
from the previous microarray analysis as well as to determine brain 
expression and distribution of the regulated gene. The results are 
shown in Figure 1. Under basal condition, we observed a weak 
expression of AGT in hypothalamic and thalamic nuclei, with little 
or no expression in cortical or limbic brain structures (Figure 1D). 
Following maternal separation angiotensinogen expression was 
signiﬁ  cantly up-regulated in the hypothalamus (MWU: p < 0.01). 
In addition, an up-regulation of this gene could also be dem-
onstrated in the ventral thalamic nucleus (MWU: p < 0.01). No 
signiﬁ  cant regulation of AGT was found in the cortex (MWU: 
p < 0.421).
EXPERIMENT 2: FUNCTIONAL VALIDATION
In order to address a possible functional consequence of the dif-
ferential regulation of AGT, the role of the brain renin-angiotensin 
system (RAS) in modulating maternal separation was addressed. 
For this experiment we chose to separate the animals for a shorter 
time period, to examine the involvement of the brain RAS in the 
activation of the HPA axis due to maternal separation. In previous 
studies we could show, that the activation of the stress system occurs 
during the ﬁ  rst 8 h of maternal separation (Schmidt et al., 2004). 
Two hours after the onset of the separation period, animals received 
an injection of either the AT(1) receptor antagonist candesartan or 
vehicle (saline). For corticosterone, ANOVA revealed a signiﬁ  cant 
effect of condition [F(1,60) = 347.077 (p < 0.0001)], but not for 
treatment [F(1,60) = 0.499 (p < 0.5)]. Maternal separation resulted 
in a robust increase in corticosterone secretion (Figure 2A). This 
effect was not different between the two treatment groups. For 
ACTH, ANOVA revealed a main effect of condition [F(1,60) = 89.59 
(p < 0.0001)] and treatment [F(1,60) = 54.018 (p < 0.0001)], as well 
as an interaction of condition and treatment [F(1,60) = 32.406 
(p < 0.0001)]. Maternal separation increased ACTH plasma levels 
compared to non-separated controls. This increase was signiﬁ  cantly 
higher in candesartan-treated pups compared to vehicle-treated 
deprived pups (Figure 2B).
brains were sectioned at −20°C in a cryostat microtome at 16 µm 
in the coronal plane through the level of the hypothalamic PVN. 
The sections were thaw-mounted on superfrost plus slides (Menzel, 
Braunschweig, Germany), dried and kept at −80°C. In-situ hybridi-
zation using 35S UTP labeled ribonucleotide probes were performed 
as described previously (Schmidt et al., 2002a). For angiotensino-
gen, riboprobe synthesis was carried out from a mouse brain cDNA 
library, yielding a 711 bp long probe (nucleotides GGATACAC + 703 
of accession no NM007428). The riboprobes for corticotropin 
releasing hormone (CRH) and the glucocorticoid receptor (GR) 
were described previously (Schmidt et al., 2003b). The slides were 
apposed to Kodak Biomax MR ﬁ  lm (Eastman Kodak Co., Rochester, 
NY, USA) and developed. Autoradiographs were digitized, and 
relative expression was determined by computer-assisted optical 
densitometry (Scion Image, Scion Corporation). The mean of four 
measurements was calculated from each animal.
DATA ANALYSIS
The microarray data were quantiﬁ  ed using the ﬁ  xed circle quan-
tiﬁ  cation method of QuantArray (PerkinElmer Life Sciences) and 
a nonlinear regression method (Yang et al., 2002) implemented in 
the statistical software R1. To correct for multiple testing, p-values 
were adjusted following the false discovery rate (FDR) method 
(Benjamini and Hochberg, 1995). An adjusted p-value of <0.05 was 
considered statistically signiﬁ  cant. Differentially expressed genes 
were imported into the BiblioSphere software V 7.20 (Genomatix, 
Munich, Germany) and assigned to Gene Ontology categories to 
identify their biological function.
For the in-situ hybridization and endocrine data, the results 
were analyzed by analysis of variance procedures (ANOVA) 
with the level of signiﬁ  cance set at p < 0.05. The initial analysis 
included sex as a factor; once it was determined that sex was not 
a signiﬁ  cant factor, the data were collapsed across this variable. 
Where appropriate, tests of simple main and interaction effects 
were made with the Mann–Whitney–U test. Data are presented 
as mean ± SEM.
RESULTS
EXPERIMENT 1: GENE EXPRESSION PROFILE
Endocrine validation
To validate the success of the maternal deprivation procedure, 
plasma corticosterone was measured. As expected, maternal sepa-
ration resulted in a signiﬁ  cant increase of circulating corticosterone 
(non-separated: 6.65 ± 1.64 ng/ml; separated: 109.01 ± 7.95 ng/ml; 
p < 0.05).
Microarray results
The data discussed in this publication have been deposited in NCBIs 
Gene Expression Omnibus (GEO)2 and are accessible through GEO 
Series accession number GSE14687. For the microarray analysis 
only genes with a fold-regulation of 1.5 or higher and an adjusted 
p-value of less than 0.05 were regarded as differentially regulated. 
Using these cut-off criteria, we identiﬁ  ed 52 differentially expressed 
1http://www.r-project.org
2http://www.ncbi.nlm.nih.gov/geo/ Frontiers in Molecular Neuroscience  www.frontiersin.org  May  2009 | Volume  2 | Article  1 | 4
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Table 1 | List of signiﬁ  cantly up-regulated genes in the PVN region of the hypothalamus in 9-day-old maternally separated mouse pups compared 
to controls.
 Gene symbol  Gene name  Function  Accession number  Fold regulation  p-Value
Rap2ip  Rap2 interacting protein  Signal transduction  AI839996  2.6876  0.0048
BC055107 BC055107  Unknown  AI836637  2.4745  0.0027
Gjb6  Gap junction membrane  Development  AI847389  2.3288  0.0027
    channel protein beta 6
DAP-3  Disks large-associated protein 3  Cell-cell signalling  AI850878  2.2489  0.0267
NA NA  Unknown  AI854246  2.1465  0.0019
2610304G08Rik  RIKEN cDNA 2610304G08 gene  Unknown  AI843346  2.0788  0.0073
Ttf2  Transcription termination factor,  Gene expression  AA473992  2.0507  0.0197
    RNA polymerase II
Paqr8  Progestin and adipoQ receptor  Unknown  AI843077  1.9711  0.0224
   family  member  VIII
Agt Angiotensinogen  Signal  transduction  AI838902  1.934  0.028
Hipk3 Homeodomain  interacting  Apoptosis  AI449703 1.9338  0.0338
    protein kinase 3
Atp1a2 ATPase,  Na+/K+ transporting,  Cell-cell signalling  AI851097  1.8715  0.0278
    alpha 2 polypeptide
Glul  Glutamate-ammonia ligase   Metabolic processes  AI835674  1.8393  0.0003
   (glutamine  synthase)
Sqrdl Sulﬁ  de quinone reductase-like (yeast)  Metabolic processes  AA473822  1.8204  0.0201
Olah  Oleoyl-ACP hydrolase  Metabolic processes  AI414810  1.775  0.0246
Cln8 Ceroid-lipofuscinosis,  neuronal  8  Apoptosis  AI843820  1.7421  0.036
Ipw  Imprinted gene in the Prader-Willi   Unknown  AI852618  1.7417  0.0355
   syndrome  region
Purb  Purine rich element binding   Apoptosis  AI854464  1.7187  0.0005
   protein  B
NA Transcribed  sequence Unknown  AI413315  1.71  0.0012
Aldo3  Aldolase 3, C isoform  Metabolic processes  AI841101  1.7039  0.0044
Ddx3y  DEAD (Asp-Glu-Ala-Asp) box   Transcription  AI448347  1.698  0.0135
   polypeptide  3,  Y-linked
Mapre2  Microtubule-associated protein,   Cellular structure  AI227140  1.6343  0.0022
    RP/EB family, member 2
1110018M03Rik  RIKEN cDNA 1110018M03 gene  Unknown  AI854593  1.6336  0.0475
Sparc  Secreted acidic cysteine   Signal transduction  AI840232  1.6115  0.0081
   rich  glycoprotein
2210013O21Rik  RIKEN cDNA 2210013021 gene  Unknown  AI846437  1.5878  0.0182
Slc24a2  Solute carrier family 24, member 2  Transport  AI847460  1.5781  0.0355
Scn2b  Sodium channel, voltage-gated,   Transport  AI840361  1.5585  0.0035
    type II, beta
Map4k4  Mitogen-activated protein kinase   Signal transduction  AI465256  1.5571  0.0427
    kinase kinase kinase 4
I125  Interleukin 25  Signal transduction  W71193  1.5411  0.0083
Cfdp  Craniofacial development protein 1  Apoptosis  AI225952  1.54  0.0062
Xpa Xeroderma  pigmentosum,    Apoptosis  AI838722  1.5375  0.0101
   complementation  group  A
Mt1  Metallothionein 1  Signal transduction  AI427514  1.525  0.012
0610007C21Rik  RIKEN cDNA 0610007C21 gene  Unknown  AI837774  1.5166  0.0221
Tmeml30  Transmembrane protein 130  Unknown  AI854455  1.5158  0.0041
Gas5  Growth arrest speciﬁ  c 5  Apoptosis  AI848205  1.5123  0.0044
Gtl2  GTL2, imprinted maternally   Proliferation  AI847231  1.5118  0.0022
    expressed untranslated mRNA
Clstn3 Calsyntenin  3  Cell-cell  signalling  AI851951 1.5075  0.0355
Lmna Lamin  A  Cellular  structure  AI845319 1.5062  0.0224Frontiers in Molecular Neuroscience  www.frontiersin.org  May  2009 | Volume  2 | Article  1 | 5
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For the CRH mRNA expression in the PVN, ANOVA revealed 
a main effect of condition [F(1,27) = 14.15  (p < 0.001)]  and 
treatment [F(1,27) = 23.404 (p < 0.0001)]. Maternal separation 
resulted in a decrease of CRH mRNA expression in the PVN in 
vehicle-treated animals (Figures 3A and B). This effect was mim-
icked by candesartan treatment in non-separated pups, resulting 
Table 2 | List of signiﬁ  cantly down-regulated genes in the PVN region of the hypothalamus in 9-day-old maternally separated mouse pups 
compared to controls.
Gene symbol  Gene name  Function  Accession number  Fold regulation  p-Value
Xist  Inactive X speciﬁ  c transcripts  Gene expression  AI227127  −2.1304 0.0062
Dcpp  Demilune cell and parotid protein  Development  AA036082  −2.1191 0.0345
NA  13 days embryo heart cDNA  Unknown  AA259358  −1.7566 0.0313
St8sia4  ST8 alpha-N-acetyl-neuraminide   Metabolic processes  AI385627  −1.6858 0.0355
   alpha-2,8-sialyltransferase  4
Hmgcs1 3-hydroxy-3-methylglutaryl-Coenzyme    Metabolic  processes  AI841574  −1.6697 0.0009
    A synthase 1
Sfrs11  Splicing factor, arginine/serine-rich 11  Apoptosis  AI465457  −1.6512 0.0056
Syt4  Synaptotagmin 4  Cell-cell signalling  AI843967  −1.6253 0.0201
NA Transcribed  sequences  Unknown  AI839136  −1.6099 0.0452
NA  7 days neonate cerebellum cDNA,  Unknown  W78304  −1.5498 0.0292
   clone:A730008E19
Slurp1  Secreted Ly6/Plaur domain containing 1  Metabolic processes  AI415082  −1.5308 0.0278
Rtn3 Reticulon  3  Apoptosis  AI852459  −1.5302 0.013
Mtap1b  Microtubule-associated protein 1 B  Development  AI852731  −1.5183 0.0104
Tcf712  Transcription factor 7-like 2, T-cell   Gene expression  AI451561  −1.516 0.0131
   speciﬁ  c, HMG-box
B230208H17Rik  RIKEN cDNA B230208H17 gene  Unknown  AI835464  −1.5151 0.0337
Zfp535 Zinc  ﬁ  nger protein 535  Unknown  AA272875  −1.5089 0.0421
FIGURE 1 | Validation of expression changes of angiotensinogen by in-situ hybridization. A signiﬁ  cant up-regulation of angiotensinogen was found in the 
PVN (A) and the ventral thalamic nucleus (B). No signiﬁ  cant expression differences were observed in the cortex (C). Figure (D) shows representative 
autoradiograph pictures of angiotensinogen mRNA expression in maternally non-separated (NSEP) and maternally separated (SEP) animals. Left arrow: ventral 
thalamic nucleus; right arrow: paraventricular nucleus. *Signiﬁ  cant from NSEP , n = 6 per group.Frontiers in Molecular Neuroscience  www.frontiersin.org  May  2009 | Volume  2 | Article  1 | 6
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GR mRNA expression was measured in the CA1 area of the 
hippocampus. ANOVA revealed a main effect of treatment 
[F(1,27) = 11.75 (p < 0.01)], as well as an interaction of condi-
tion and treatment [F(1,27) = 9.951 (p < 0.01)]. In vehicle-treated 
in   signiﬁ  cantly lower CRH mRNA expression levels compared to 
vehicle controls. The lowest CRH mRNA expression was observed 
in maternally separated animals, which received a candesartan 
treatment 6 h before testing.
FIGURE 2 | Effects of candesartan treatment in non-separated (NSEP) and 
separated (SEP) mouse pups on corticosterone (A) and ACTH (B) plasma 
values. Maternal separation increased corticosterone and ACTH secretion. 
No effects of candesartan treatment were seen for corticosterone. For 
ACTH, candesartan treatment resulted in a signiﬁ  cant increase of 
ACTH secretion compared to vehicle-treated pups of the same condition. 
*Signiﬁ  cant from NSEP , #signiﬁ  cant from vehicle treatment, n = 16
per group.
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FIGURE 3 | Effects of candesartan treatment in non-separated (NSEP) and 
separated (SEP) mouse pups on CRH mRNA expression (A) in the PVN 
and GR mRNA expression (C) in the CA1 region of the hippocampus. CRH 
mRNA expression was signiﬁ  cantly decreased by maternal separation and 
candesartan treatment. The lowest expression of CRH was observed in 
candesartan-treated, separated mouse pups. GR expression was not 
affected by maternal separation or candesartan treatment. However, when 
combined we observed a signiﬁ  cant down-regulation of GR mRNA 
expression. (B) and (D): Representative autoradiograms of CRH mRNA 
expression in the PVN and GR mRNA expression in the hippocampus, 
respectively. *Signiﬁ  cant from NSEP , #signiﬁ  cant from vehicle treatment, n = 8 
per group.Frontiers in Molecular Neuroscience  www.frontiersin.org  May  2009 | Volume  2 | Article  1 | 7
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animals, GR mRNA expression was not altered by 8 h of maternal 
separation. Candesartan treatment of non-separated pups did also 
not alter GR mRNA   expression. However, maternally separated 
pups, which were treated with candesartan, showed a signiﬁ  cantly 
decreased GR mRNA expression compared to saline treated, 
 separated pups as well as compared to non-separated, candesartan-
treated pups (Figures 3C and D).
DISCUSSION
Early trauma has been shown to result in lasting consequences and 
an increased risk for a number of diseases, including psychiatric 
disorders (Chapman et al., 2004; Dong et al., 2004; Heim et al., 
2008). The mechanism by which trauma affects health is so far not 
understood completely.
To study the underlying molecular mechanisms that lead to 
disease, animal models as maternal separation have been used 
to model early traumatic events. Numerous groups have shown 
that the paradigm of maternal separation results in long-lasting 
neuroendocrine and behavioral consequences, thereby mimicking 
the human situation of early trauma (Ladd et al., 1996; Macri and 
Laviola, 2004; Oitzl et al., 2000; Rots et al., 1996; Suchecki et al., 
2000; Sutanto et al., 1996; Workel et al., 2001). In the current 
study, we examined gene expression changes which occur as a 
direct consequence of a single 24-h maternal separation period in 
order to identify signal cascades and brain systems that are regu-
lated by maternal separation. This speciﬁ  c paradigm was chosen 
as the single separation episode is clearly deﬁ  ned in time and 
issues of adaptation to the separation can be avoided (Enthoven 
et al., 2008). We focused on the area of the hypothalamic PVN, as 
this brain region plays a key role in regulating HPA axis activity. 
Our unbiased, microarray-based approach resulted in the iden-
tiﬁ  cation of 52 differentially regulated genes. The majority of 
the regulated genes were found to be up-regulated (37), while 
only 15 genes were down-regulated as a consequence of maternal 
separation.
One of the highest regulated genes was the angiotensinogen 
gene, which we independently validated by in-situ hybridization. 
Angiotensinogen is the precursor of angiotensin I that in turn 
is transformed into angiotensin II which is the primary effector 
of the brain renin-angiotensin system (RAS). First postulated in 
1971 (Ganten et al., 1971), the main functions of the brain RAS 
are regulation of ﬂ  uid electrolyte homeostasis and modulation of 
cardiovascular responses (Johnson and Thunhorst, 1997; Phillips 
and Sumners, 1998). However, this brain system has also been 
implicated in the regulation of memory, cognition, addiction as 
well as stress system regulation and has been associated with mood 
disorders (Belcheva et al., 2000; Saab et al., 2007; Saavedra et al., 
2004). We therefore chose to further investigate, whether the acti-
vation of angiotensinogen after maternal separation might be of a 
functional consequence for the function of the stress system in the 
neonate. For the pharmacological validation of the involvement of 
angiotensinogen in modulating HPA axis activity we focused on the 
ﬁ  rst 8 h of the separation period, as we have previously shown that 
activation occurs during this time (Schmidt et al., 2004).
We found robust changes in ACTH release following applica-
tion of the AT(1) receptor antagonist candesartan in maternally 
separated animals. This change in ACTH release was not reﬂ  ected 
in the corticosterone secretion at that time point. There are vari-
ous possible explanations for this phenomenon. Numerous reports 
indicate that activation of AT(1) receptors increases corticosterone 
release from the adrenal cortex (Aguilar et al., 2004; Nithipatikom 
et al., 2005). This mechanism might also be involved in increas-
ing adrenal sensitivity and adrenal corticosterone secretion during 
maternal separation. Alternatively this effect might be due to a 
contributing impact of the AT(2) receptor. Blockade of the AT(1) 
receptor results in increased circulating angiotensin II (Campbell, 
1996), which is in turn stimulating the AT(2) receptor (Siragy and 
Carey, 2000). Blockade of AT(1) receptors with candesartan might 
thus on one hand activate the central part of the HPA axis, but block 
corticosterone release at the adrenal level. Alternatively, high ACTH 
levels at the time of testing could result in a higher corticosterone 
secretion at later time points.
In the brain, candesartan treatment in non-separated mouse 
pups mimicked the effects of maternal separation. CRH mRNA 
expression was equally decreased after maternal separation and 
candesartan treatment. This ﬁ  nding is intriguing, as the decrease 
of CRH expression following maternal separation remains a puz-
zling phenomenon. Our data indicate that the brain RAS might 
be directly involved in regulation of CRH mRNA expression in 
the neonate, independent of peripheral corticosterone concentra-
tions. These data are in line with reports in adult animals, where 
angiotensin II was found to increase CRH mRNA expression in the 
PVN, an area where predominantly the AT(1) receptor is expressed 
(Sumitomo et al., 1991). Further, a blockade of AT(1) receptors 
seemed to exponentiate the central effects of maternal separation. 
The lowest expression levels of CRH mRNA in the PVN were found 
in candesartan-treated, maternally separated animals. In this group 
we also detected a decrease in GR mRNA in the hippocampus, 
a process that normally occurs only at longer separation periods 
(Schmidt et al., 2004). These data are in contrast to the adult situ-
ation, where the brain RAS has mostly been found to activate the 
stress system (Saavedra and Benicky, 2007), suggesting a different 
role of the brain RAS in the developing brain. This hypothesis is 
further supported by the different AT(1) receptor distribution dur-
ing development and adulthood (Millan et al., 1991; Nuyt et al., 
2001; Shanmugam et al., 1995).
Angiotensinogen is a precursor protein for a number of differ-
ent cleavage products that act on at least four different angiotensin 
receptors in the brain (Phillips and de Oliveira, 2008). While in 
the current manuscript we observed a clear effect by blocking the 
AT(1) receptor, an additional involvement of the AT(2) or AT(4) 
receptors can not be excluded. Both receptors are expressed in 
the PVN (von Bohlen und Halbach and Albrecht, 2006). While 
treatment with an angiotensin converting enzyme (ACE) inhibi-
tor should have similar effects compared to candesartan treat-
ment, additional studies using speciﬁ  c AT(2) or AT(4) antagonists 
are needed to unravel the role of these receptors in the effects of 
maternal deprivation.
As different postnatal stress paradigms, including 24-h mater-
nal separation, have long-lasting physiological and behavioral 
consequences, it is intriguing to speculate which role the brain 
RAS might play in these effects. On one hand, early life stress 
effects could lastingly affect the function of the brain RAS, thereby 
inﬂ  uencing the development or the adult reactivity of the stress Frontiers in Molecular Neuroscience  www.frontiersin.org  May  2009 | Volume  2 | Article  1 | 8
Liebl et al.  RAS and maternal deprivation
system. On the other hand, the lasting effects of early life stress 
could be dependent on speciﬁ  c genetic risk alleles, similar to e.g. 
the serotonin transporter or the CRH receptor type 1 (Bradley 
et al., 2008; Caspi et al., 2003). However, while polymorphisms in 
the brain RAS have been linked to depression and bipolar disorder 
(Meira-Lima et al., 2000; Saab et al., 2007), we are not aware of 
any study investigating the interaction of these polymorphisms 
with e.g. childhood trauma.
In summary, our data indicate that during postnatal devel-
opment the brain RAS functions to suppress HPA axis activity. 
Blockade of this system results in a central (but not peripheral) 
activation of the HPA axis under basal conditions and enhances 
the response to maternal separation. Thus, the up-regulation of 
angiotensinogen after maternal separation functions to suppress 
the separation-induced activation of the stress system.
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